Company: BDRX
Filing Date: 2025-01-17
Form Type: F-1
Source: 0001214659-25-000922
Chunk: 422

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-17
Form: F-1
Chunk 422
---
 or (b)(7) as part of a registration                                  
 statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing     
 the information required by section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration        
 statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of        
 sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any        
 person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating       
 to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall      
 be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus   
 that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration       
 statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such      
 effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration 
 statement or made in any such document immediately prior to such effective date.                                                              |

Insofar as indemnification
for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant
to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission
such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for
indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer
or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer
or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the
matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question of whether such indemnification
by it is against public policy as expressed in the Act and will be governed by the